Clinical implications of the serum CA19-9 level in “biological borderline resectability” and “biological downstaging” in the setting of preoperative chemoradiation therapy for pancreatic cancerHidenori Takahashi, Osamu Ishikawa, Daisaku Yamada et al.|Pancreatology|2020Cited by 63
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control studyHirofumi Akita, Masato Sakon, Satoko Marukawa et al.|Clinical Nutrition ESPEN|2019Cited by 56
Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal CancerTomoyuki Matsunaga, Masahiko Yano, Hiroshi Miyata et al.|Anticancer Research|2018Cited by 51
Prognostic Implication of Postoperative Weight Loss After Esophagectomy for Esophageal Squamous Cell CancerYuto Kubo, Masahiko Yano, Hiroshi Miyata et al.|Annals of Surgical Oncology|2020Cited by 38
Comparison of the modified Collard and hand‐sewn anastomosis for cervical esophagogastric anastomosis after esophagectomy in esophageal cancer patients: A propensity score‐matched analysisKeijiro Sugimura, Masahiko Yano, Hiroshi Miyata et al.|Annals of Gastroenterological Surgery|2018Cited by 36